Urovant Sciences to Present at the Jefferies Virtual Healthcare Conference
IRVINE, Calif. and BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) announced today that President and Chief Executive Officer James Robinson will…
Pharmaceuticals, Biotechnology and Life Sciences
IRVINE, Calif. and BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) announced today that President and Chief Executive Officer James Robinson will…
IRVINE, Calif. and BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) announced today that President and Chief Executive Officer James Robinson will…
IRVINE, Calif. and BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) announced today that President and Chief Executive Officer James Robinson will…
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) (“Teva”), announced today that, in the interest of the…
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) (“Teva”), announced today that, in the interest of the…
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) (“Teva”), announced today that, in the interest of the…
LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in…
LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in…
LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in…
GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of…